[{"data":1,"prerenderedAt":252},["ShallowReactive",2],{"options:asyncdata:$edqCtX92v0:/blogs/kenya-announces-major-reduction-in-cancer-treatment-costs-through-pfizer-partnership:0":3},{"blogPost":4,"otherBlogs":82},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":6,"modified_gmt":6,"slug":9,"status":10,"type":11,"link":12,"title":13,"content":15,"excerpt":18,"author":20,"featured_media":21,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":25,"categories":27,"tags":28,"class_list":29,"featured_media_src_url":37,"_links":38},704,"2026-09-01T09:58:04",{"rendered":8},"https://wp.ncikenya.go.ke/?p=704","kenya-announces-major-reduction-in-cancer-treatment-costs-through-pfizer-partnership","publish","post","https://wp.ncikenya.go.ke/2026/09/01/kenya-announces-major-reduction-in-cancer-treatment-costs-through-pfizer-partnership/",{"rendered":14},"Kenya Announces Major Reduction in Cancer Treatment Costs Through Pfizer Partnership",{"rendered":16,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya has secured a major breakthrough in reducing the cost of cancer treatment following an agreement between the Government of Kenya and global pharmaceutical company Pfizer, aimed at lowering the cost of selected cancer medicines.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The National Cancer Institute of Kenya (NCI-K) is pleased to announce that the agreement could reduce the cost of treating several cancers by more than seven times, with the cost of some medicines expected to fall from as much as KSh. 1 million to below KSh. 50,000 per treatment cycle.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The development follows discussions between President William Ruto and Pfizer Chairman and Chief Executive Officer Albert Bourla during their meeting at State House, Nairobi.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The agreement covers medicines used in the treatment of breast, stomach, colorectal, lung, prostate and oesophageal cancers, as well as leukaemia, lymphoma and multiple myeloma.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>“Today, Kenya has made a breakthrough in the treatment of several cancers,” President Ruto said.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The arrangement brings together Pfizer and the Kenya Medical Supplies Authority (KEMSA) under Pfizer’s \u003Cem>Accord for a Healthier World\u003C/em>, a global initiative through which the company provides medicines to lower-income countries on a not-for-profit basis. Kenya joined the Accord in June 2025.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The significant reduction in medicine costs is expected to improve access to cancer treatment and ease the financial burden faced by patients and their families. According to the President, the lower prices will enable the Social Health Authority (SHA) KSh. 800,000 cancer package to fully cover treatment, substantially reducing the need for additional out-of-pocket payments.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The agreement will also provide Kenya with access to newer cancer therapies, helping address delays that patients have historically experienced in accessing innovative and potentially life-saving treatments.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>In addition, Pfizer is expected to make relevant technologies and newer medicines available to support local pharmaceutical manufacturing in Africa, contributing to efforts to strengthen the continent’s capacity to produce essential medical commodities.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>This development comes at a critical time as cancer continues to pose a major public health challenge in Kenya. The high cost of diagnosis and treatment has for years placed a significant financial burden on patients and families, with some patients unable to complete their prescribed treatment.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The National Cancer Institute of Kenya (NCI-K) welcomes this landmark development as an important step towards advancing equitable access to quality, affordable and timely cancer care. The partnership reinforces Kenya’s commitment to reducing the financial barriers to cancer treatment and strengthening the country’s broader cancer control efforts.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Towards a Cancer-Free Nation.\u003C/strong>\u003C/p>\n",false,{"rendered":19,"protected":17},"\u003Cp>Kenya has secured a major breakthrough in reducing the cost of cancer treatment following an agreement between the Government of Kenya and global pharmaceutical company Pfizer, aimed at lowering the cost of selected cancer medicines. The National Cancer Institute of Kenya (NCI-K) is pleased to announce that the agreement could reduce the cost of treating […]\u003C/p>\n",1,705,"open","","standard",{"pagelayer_contact_templates":26,"_pagelayer_content":23,"footnotes":23},[],[20],[],[30,11,31,32,33,34,35,36],"post-704","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/5807a4d5-f491-4f23-9e6d-150ccd688d09_HREKm0GXkAElEp1-og_image.webp",{"self":39,"collection":45,"about":48,"author":51,"replies":55,"version-history":58,"predecessor-version":61,"wp:featuredmedia":65,"wp:attachment":68,"wp:term":71,"curies":78},[40],{"href":41,"targetHints":42},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/704",{"allow":43},[44],"GET",[46],{"href":47},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts",[49],{"href":50},"https://wp.ncikenya.go.ke/wp-json/wp/v2/types/post",[52],{"embeddable":53,"href":54},true,"https://wp.ncikenya.go.ke/wp-json/wp/v2/users/1",[56],{"embeddable":53,"href":57},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=704",[59],{"count":20,"href":60},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/704/revisions",[62],{"id":63,"href":64},706,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/704/revisions/706",[66],{"embeddable":53,"href":67},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/705",[69],{"href":70},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=704",[72,75],{"taxonomy":73,"embeddable":53,"href":74},"category","https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=704",{"taxonomy":76,"embeddable":53,"href":77},"post_tag","https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=704",[79],{"name":80,"href":81,"templated":53},"wp","https://api.w.org/{rel}",[83,135,195],{"id":84,"date":85,"date_gmt":85,"guid":86,"modified":85,"modified_gmt":85,"slug":88,"status":10,"type":11,"link":89,"title":90,"content":92,"excerpt":94,"author":20,"featured_media":95,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":96,"categories":98,"tags":99,"class_list":100,"featured_media_src_url":102,"_links":103},701,"2026-08-14T13:52:50",{"rendered":87},"https://wp.ncikenya.go.ke/?p=701","the-nci-k-frequently-asked-questions","https://wp.ncikenya.go.ke/2026/08/14/the-nci-k-frequently-asked-questions/",{"rendered":91},"THE NCI-K FREQUENTLY ASKED QUESTIONS",{"rendered":93,"protected":17},"\n\u003Cdiv data-wp-interactive=\"core/file\" class=\"wp-block-file\">\u003Cobject data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" type=\"application/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of FREQUENTLY ASKED QUESTIONS.\">\u003C/object>\u003Ca id=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\" href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\">FREQUENTLY ASKED QUESTIONS\u003C/a>\u003Ca href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\">Download\u003C/a>\u003C/div>\n",{"rendered":23,"protected":17},0,{"pagelayer_contact_templates":97,"_pagelayer_content":23,"footnotes":23},[],[20],[],[101,11,31,32,33,35,36],"post-701",null,{"self":104,"collection":109,"about":111,"author":113,"replies":115,"version-history":118,"predecessor-version":121,"wp:attachment":125,"wp:term":128,"curies":133},[105],{"href":106,"targetHints":107},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701",{"allow":108},[44],[110],{"href":47},[112],{"href":50},[114],{"embeddable":53,"href":54},[116],{"embeddable":53,"href":117},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=701",[119],{"count":20,"href":120},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions",[122],{"id":123,"href":124},703,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions/703",[126],{"href":127},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=701",[129,131],{"taxonomy":73,"embeddable":53,"href":130},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=701",{"taxonomy":76,"embeddable":53,"href":132},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=701",[134],{"name":80,"href":81,"templated":53},{"id":136,"date":137,"date_gmt":137,"guid":138,"modified":137,"modified_gmt":137,"slug":140,"status":10,"type":11,"link":141,"title":142,"content":144,"excerpt":146,"author":20,"featured_media":148,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":149,"categories":151,"tags":154,"class_list":155,"featured_media_src_url":159,"_links":160},736,"2026-10-06T18:27:09",{"rendered":139},"https://wp.ncikenya.go.ke/?p=736","nci-k-hosts-ampath-flow-cytometry-team-to-strengthen-cancer-diagnostic-services","https://wp.ncikenya.go.ke/2026/10/06/nci-k-hosts-ampath-flow-cytometry-team-to-strengthen-cancer-diagnostic-services/",{"rendered":143},"NCI-K Hosts AMPATH Flow Cytometry Team to Strengthen Cancer Diagnostic Services.",{"rendered":145,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute of Kenya (NCI-K) today hosted a team from the AMPATH Flow Cytometry Program (AFCP) for a meeting with the NCI-K leadership. The team was received by the Director of the Cancer Prevention and Control Directorate, Dr. Nashat Fadhloon Noor.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement focused on strengthening collaboration and advancing cancer diagnosis through specialized laboratory technologies, including flow cytometry, which plays an important role in the diagnosis and management of several cancers, particularly haematological malignancies.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Key areas discussed included:\u003C/p>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Recognition of flow cytometry as an essential specialized cancer diagnostic service.\u003C/li>\n\n\n\n\u003Cli>Adoption of panel-based reimbursement rather than individual antibody-based reimbursement.\u003C/li>\n\n\n\n\u003Cli>Appropriate reimbursement for immunohistochemistry (IHC) panels.\u003C/li>\n\n\n\n\u003Cli>Development of national technical and quality standards for specialized cancer diagnostics.\u003C/li>\n\n\n\n\u003Cli>Establishment of coordinated specimen-referral pathways.\u003C/li>\n\n\n\n\u003Cli>Recognition of qualified reference laboratories to support testing, training and quality assurance.\u003C/li>\n\u003C/ul>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The AMPATH delegation included Dr. Teresa Lotodo, Lead Pathologist and Chair, Pathology Department, Moi University & Medical Director, Flow Cytometry Laboratory; Raphael Koima, AFCP Program Manager/Coordinator; Dr. Gilbert Olbara, Lead Clinician and Head of Paediatric Oncology, MTRH; Dr. Ronald Tonui, Director, AMPATH Reference Laboratory; and Nicholas Kigen, Lead Laboratory Scientist, ARL.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The meeting reaffirmed the importance of strategic partnerships, innovation and strengthened diagnostic capacity in improving early and accurate cancer diagnosis and ultimately advancing Kenya’s cancer response.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-K remains committed to building partnerships that strengthen cancer prevention, diagnosis, treatment and care towards a cancer-free nation.\u003C/p>\n",{"rendered":147,"protected":17},"\u003Cp>The National Cancer Institute of Kenya (NCI-K) today hosted a team from the AMPATH Flow Cytometry Program (AFCP) for a meeting with the NCI-K leadership. The team was received by the Director of the Cancer Prevention and Control Directorate, Dr. Nashat Fadhloon Noor. The engagement focused on strengthening collaboration and advancing cancer diagnosis through specialized […]\u003C/p>\n",737,{"pagelayer_contact_templates":150,"_pagelayer_content":23,"footnotes":23},[],[152,153],4,43,[],[156,11,31,32,33,34,35,157,158],"post-736","category-news-updates","category-partnerships","https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/DSC_5500.JPG-1024x683.jpeg",{"self":161,"collection":166,"about":168,"author":170,"replies":172,"version-history":175,"predecessor-version":178,"wp:featuredmedia":182,"wp:attachment":185,"wp:term":188,"curies":193},[162],{"href":163,"targetHints":164},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/736",{"allow":165},[44],[167],{"href":47},[169],{"href":50},[171],{"embeddable":53,"href":54},[173],{"embeddable":53,"href":174},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=736",[176],{"count":20,"href":177},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/736/revisions",[179],{"id":180,"href":181},738,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/736/revisions/738",[183],{"embeddable":53,"href":184},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/737",[186],{"href":187},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=736",[189,191],{"taxonomy":73,"embeddable":53,"href":190},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=736",{"taxonomy":76,"embeddable":53,"href":192},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=736",[194],{"name":80,"href":81,"templated":53},{"id":196,"date":197,"date_gmt":197,"guid":198,"modified":197,"modified_gmt":197,"slug":200,"status":10,"type":11,"link":201,"title":202,"content":204,"excerpt":206,"author":20,"featured_media":208,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":209,"categories":211,"tags":212,"class_list":213,"featured_media_src_url":215,"_links":216},669,"2026-05-29T07:10:19",{"rendered":199},"https://wp.ncikenya.go.ke/?p=669","kenya-advances-technology-driven-cancer-care","https://wp.ncikenya.go.ke/2026/05/29/kenya-advances-technology-driven-cancer-care/",{"rendered":203},"Kenya Advances Technology-Driven Cancer Care.",{"rendered":205,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, joined the Cabinet Secretary for Health, Hon. Aden Duale, during a strategic engagement at Afya House with Prof. Eric Ford, Director and Vice-Chair of Medical Physics at the University of Washington and member of Bio Ventures for Global Health (BVGH), aimed at accelerating the transformation of Kenya’s cancer care system under the Universal Health Coverage agenda.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-1024x682.jpeg\" alt=\"\" class=\"wp-image-671\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-1024x682.jpeg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-300x200.jpeg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-768x512.jpeg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1.jpeg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>Health CS, Hon. Aden Duale, leading the meeting\u003C/em>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The discussions focused on the growing role of AI-enabled technologies, including systems already in use at Kenyatta National Hospital, in improving diagnostic precision, strengthening clinical decision-making, and enhancing efficiency in oncology care delivery.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The meeting also explored expansion of radiotherapy services, strengthening referral linkages between national and regional cancer centres, digital learning platforms for specialized oncology training, early cancer detection through community health systems, and improved access to essential oncology medicines.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement reaffirmed a shared commitment to practical, technology-driven solutions that improve access, quality, and equity in cancer care delivery across the country. The Cabinet Secretary was joined by Dr. Stephen Muleshe, Director of Public Health and Sanitation, Dr. Isaak Bashir, Director of Family Health, and other senior Ministry of Health officials.\u003C/p>\n",{"rendered":207,"protected":17},"\u003Cp>The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, joined the Cabinet Secretary for Health, Hon. Aden Duale, during a strategic engagement at Afya House with Prof. Eric Ford, Director and Vice-Chair of Medical Physics at the University of Washington and member of Bio Ventures for Global Health (BVGH), […]\u003C/p>\n",672,{"pagelayer_contact_templates":210,"_pagelayer_content":23,"footnotes":23},[],[152,153],[],[214,11,31,32,33,34,35,157,158],"post-669","https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066874129-1024x679.jpeg",{"self":217,"collection":222,"about":224,"author":226,"replies":228,"version-history":231,"predecessor-version":235,"wp:featuredmedia":239,"wp:attachment":242,"wp:term":245,"curies":250},[218],{"href":219,"targetHints":220},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/669",{"allow":221},[44],[223],{"href":47},[225],{"href":50},[227],{"embeddable":53,"href":54},[229],{"embeddable":53,"href":230},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=669",[232],{"count":233,"href":234},2,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/669/revisions",[236],{"id":237,"href":238},674,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/669/revisions/674",[240],{"embeddable":53,"href":241},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/672",[243],{"href":244},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=669",[246,248],{"taxonomy":73,"embeddable":53,"href":247},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=669",{"taxonomy":76,"embeddable":53,"href":249},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=669",[251],{"name":80,"href":81,"templated":53},1792071276723]